Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Increases By 100.0%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 400 shares, an increase of 100.0% from the November 30th total of 200 shares. Based on an average daily trading volume, of 2,900 shares, the short-interest ratio is currently 0.1 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

Shares of First Trust Nasdaq Pharmaceuticals ETF stock traded down $0.15 during midday trading on Friday, hitting $27.24. The company had a trading volume of 1,314 shares, compared to its average volume of 4,948. The business’s 50 day simple moving average is $27.95 and its two-hundred day simple moving average is $28.25. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72. The stock has a market cap of $16.34 million, a PE ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently declared a dividend, which will be paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th will be issued a $0.1304 dividend. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13. The ex-dividend date of this dividend is Friday, December 13th.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

A hedge fund recently bought a new stake in First Trust Nasdaq Pharmaceuticals ETF stock. International Assets Investment Management LLC purchased a new position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,662 shares of the company’s stock, valued at approximately $73,000. International Assets Investment Management LLC owned approximately 0.41% of First Trust Nasdaq Pharmaceuticals ETF as of its most recent SEC filing.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.